Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.770
+0.090 (2.45%)
Nov 13, 2026, 4:00 PM EST - Market closed

Fulcrum Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
116.41197.5358.2125.5635.135.41
Short-Term Investments
190.14154.77182.81210.66167.82182.75
Cash & Short-Term Investments
306.55352.31241.02236.22202.92218.16
Cash Growth
52.78%46.17%2.03%16.41%-6.99%93.21%
Accounts Receivable
--2.10.540.233.64
Other Receivables
1.311.071.251.710.850.47
Receivables
1.311.073.342.251.084.11
Prepaid Expenses
1.854.15.563.733.523.73
Total Current Assets
310.8357.48249.92242.2207.52226
Property, Plant & Equipment
-7.079.5812.3915.977.37
Other Long-Term Assets
0.011.741.213.13.21.63
Total Assets
310.81366.28260.72257.69226.69235

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.511.591.162.763.644.79
Accrued Expenses
1.138.797.238.339.459.16
Current Portion of Leases
6.832.42.192.192.6-
Current Unearned Revenue
----0.934.71
Other Current Liabilities
0.130.260.460.40.110.54
Total Current Liabilities
8.5913.0511.0413.6816.7319.2
Long-Term Leases
-4.046.448.6310.82-
Other Long-Term Liabilities
0.20.20.20.20.24.26
Total Liabilities
8.7817.2817.6822.527.7423.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.070.050.060.050.04
Additional Paid-In Capital
953943.04762.25744.94612.03514.36
Retained Earnings
-650.29-594.28-519.4-509.67-412.34-302.47
Comprehensive Income & Other
-0.760.170.13-0.14-0.8-0.4
Total Common Equity
302.03349243.03235.19198.94211.54
Shareholders' Equity
302.03349243.03235.19198.94211.54
Total Liabilities & Equity
310.81366.28260.72257.69226.69235

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6.836.448.6310.8213.42-
Net Cash (Debt)
299.72345.86232.39225.4189.5218.16
Net Cash Growth
54.79%48.83%3.10%18.95%-13.14%93.24%
Net Cash Per Share
4.075.463.753.684.216.17
Filing Date Shares Outstanding
76.3866.653.9861.9461.7640.63
Total Common Shares Outstanding
76.3866.5853.9761.9252.140.63
Working Capital
302.22344.43238.88228.52190.79206.8
Book Value Per Share
3.955.244.503.803.825.21
Tangible Book Value
302.03349243.03235.19198.94211.54
Tangible Book Value Per Share
3.955.244.503.803.825.21
Machinery
0.9911.1510.8410.6810.249.15
Construction In Progress
----0.03-
Leasehold Improvements
-7.127.127.17.16.29
SEC Filings: 10-K · 10-Q